Glooko Announces Acquisition of Monarch Medical Technologies, Maker of EndoTool Glucose Management System, to Expand Connected Diabetes Care Offerings

Procurement Prolongs Glooko’s Diabetic issues Digital Wellness System right into Hospitals, Producing a Thorough Inpatient-to-Outpatient Diabetic Issues Administration Connected Treatment Service

Offer Highlights Glooko’s Dedication to Accelerating Development and Advancement in Diabetic Issues Treatment

Glooko, Inc., a leading supplier of remote person surveillance and electronic health and wellness services for diabetic issues, today revealed that it has actually gotten Monarch Medical Technologies, the designer of the EndoTool Sugar Administration System. EndoTool is an industry-leading software application system for inpatient insulin application and glycemic administration. This critical purchase increases Glooko’s linked treatment abilities right into inpatient glycemic administration, matching its solid structure in outpatient diabetic issues administration and forming the future of a solitary, incorporated option that will certainly sustain people and medical professionals throughout the complete continuum of treatment.

” This purchase stands for an essential action in Glooko’s goal to change diabetic issues administration in every treatment setup,” stated Mike Alvarez, President at Glooko. “We have actually developed a solid structure in the outpatient area– streamlining diabetic issues administration for medical professionals via merged tool combination, EHR connection, and workable understandings. By including King’s tried and tested inpatient insulin application competence, we’re currently distinctively placed to supply a really thorough hospital-to-home option that can enhance end results, simplify operations, and improve person security. Looking in advance, this system additionally develops chances to expand our management right into medical care and progressed glycemic administration, allowing us to offer people and suppliers throughout the complete continuum of treatment.”

Inpatient glycemic administration is essential to person security, end results, and health center efficiency, with 30– 40% of hospitalized people calling for insulin treatment to preserve appropriate sugar control. Poor sugar administration can result in severe problems, longer remains, and greater prices. EndoTool, an FDA-cleared software application system that aids medical professionals in enhancing insulin application for hospitalized people, utilizes a copyrighted, patient-specific formula to supply exact, guideline-aligned insulin application in actual time, minimizing the threat of hypoglycemia and assisting health centers satisfy CMS top quality actions while simplifying scientific operations.

” Reliable glycemic administration does not start or finish at the health center doors. It’s a constant trip,” stated Mark Clements, M.D., Ph.D., Principal Medical and Method Police Officer at Glooko. “With brand-new CMS top quality actions and HEDIS metrics driving the requirement for constant sugar control, attached services are no more optional; they’re crucial. By incorporating EndoTool with Glooko’s outpatient system, our team believe we will certainly be far better able to make certain more secure treatment shifts for individuals with diabetic issues, assistance health centers satisfy top quality and governing needs, and supply quantifiable enhancements in person end results throughout the continuum.”

The purchase of King Medical advancements Glooko’s critical concentrate on linked treatment in diabetic issues administration. Glooko’s system, made use of by numerous people and greater than 8,000 facilities worldwide, accumulations information from greater than 200 linked tools– consisting of blood sugar meters, insulin pumps, continual sugar displays (CGMs), and others– to make diabetic issues administration less complicated for endocrinologists, medical care suppliers, registered nurses, diabetic issues instructors, dietitians, and various other medical professionals by unifying information from a range of tools onto a solitary system, incorporating efficiently with EHR operations, and providing workable understandings. By including EndoTool to its system, Glooko will certainly sustain severe treatment setups with accuracy insulin application formulas and remain to sustain those people post-discharge by means of its remote surveillance devices. This incorporated method intends to minimize health center readmissions, improve connection of treatment, and enhance general glycemic control throughout setups.

The mixed business will certainly preserve all existing offerings and assistance for both Glooko and EndoTool clients. In the close to term, Glooko and King Medical will certainly remain to run their items as they do today, making sure no interruption for customers. Longterm, Glooko prepares to incorporate both offerings on a solitary system.

Structure on Solid Financier Support

This purchase complies with Glooko’s $100 million Collection F funding round finished in October 2024, led by Georgian with engagement from Canaan Allies, Wellness Stimulant Resources, Mayo Ventures, Awareness Resources Allies, and various other critical capitalists. During that time, Glooko detailed its intent to increase development via both item technology and discerning procurements. The enhancement of King Medical shows just how that resources and capitalist assistance are sustaining Glooko’s technique to broaden its linked treatment system, expand its reach right into brand-new treatment setups, and strengthen its placement as a worldwide leader in electronic health and wellness for diabetic issues administration.

Regards to the purchase are not being divulged.

Concerning Glooko

Glooko is concentrated on enhancing health and wellness end results for individuals with diabetic issues via our individualized, smart, linked treatment system. Our tried and tested modern technologies enhance links in between people and suppliers, drive person involvement and adherence by means of electronic rehabs, with greater than 4.4 million individuals worldwide that have actually made use of the Glooko system. By effortlessly incorporating with digital health and wellness documents (EHRs), offering a linked tool environment, and providing workable understandings, Glooko intends to improve scientific operations and enhance end results for individuals with diabetic issues and their treatment suppliers. To learn more, please browse through glooko.com.

Concerning King Medical Technologies

King Medical is the Charlotte, NC-based manufacturer of the EndoTool Sugar Administration System, a leading business option for inpatient glycemic control. Started by medical professionals, King’s goal is to enhance person security and end results via exact insulin application innovation. The EndoTool system has actually been taken on by health centers and health and wellness systems throughout the USA to systematize and maximize insulin treatment, basically getting rid of serious hypoglycemia and minimizing hyperglycemia in crucial treatment setups. To learn more, browse through monarchmedtech.com.

Initially revealed September 23rd, 2025